治疗方案-话题@MedSci

#治疗方案#

313篇内容 | 3228人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1905043, encodeId=2a431905043a1, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=JAMA：体外放疗+雄激素剥夺治疗+近距离治疗是Gleason评分9-10分前列腺癌患者更佳治疗方案, objectType=article, longId=131723, objectId=6b88131e239c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b88131e239c, replyNumber=0, likeNumber=54, createdTime=2018-12-08, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b88131e239c, moduleTitle=JAMA：体外放疗+雄激素剥夺治疗+近距离治疗是Gleason评分9-10分前列腺癌患者更佳治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b88131e239c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905057, encodeId=f2bd190505e90, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=曙光！老年不稳定性心绞痛或将迎来新的治疗方案, objectType=article, longId=138468, objectId=43ac1384682b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43ac1384682b, replyNumber=0, likeNumber=62, createdTime=2018-08-26, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43ac1384682b, moduleTitle=曙光！老年不稳定性心绞痛或将迎来新的治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43ac1384682b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905035, encodeId=0fd11905035a2, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=J Endod：牙髓病医师的牙髓再生治疗方案：一项网络调查, objectType=article, longId=124405, objectId=d04f1244053c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d04f1244053c, replyNumber=0, likeNumber=72, createdTime=2018-04-03, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d04f1244053c, moduleTitle=J Endod：牙髓病医师的牙髓再生治疗方案：一项网络调查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d04f1244053c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905027, encodeId=df21190502ecd, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Leuk Lymphoma：急性白血病老年患者应采用何种治疗方案？, objectType=article, longId=119275, objectId=1bf51192e523, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1bf51192e523, replyNumber=0, likeNumber=68, createdTime=2018-04-26, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1bf51192e523, moduleTitle=Leuk Lymphoma：急性白血病老年患者应采用何种治疗方案？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1bf51192e523)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905033, encodeId=cbea190503303, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=J Endod：CBCT对颈部外吸收治疗方案以及一项新型轴向片层分类系统的影响, objectType=article, longId=123857, objectId=0a4512385e45, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a4512385e45, replyNumber=0, likeNumber=56, createdTime=2018-10-19, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a4512385e45, moduleTitle=J Endod：CBCT对颈部外吸收治疗方案以及一项新型轴向片层分类系统的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a4512385e45)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905022, encodeId=347e1905022db, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=JACC：他汀相关肌肉疾病的患者如何优化胆固醇治疗方案？, objectType=article, longId=115729, objectId=b961115e2991, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b961115e2991, replyNumber=0, likeNumber=111, createdTime=2018-05-21, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b961115e2991, moduleTitle=JACC：他汀相关肌肉疾病的患者如何优化胆固醇治疗方案？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b961115e2991)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905036, encodeId=4279190503614, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Hepatology：“普通”vs“优先”丙肝治疗方案哪个更具有成本效果？, objectType=article, longId=124958, objectId=8a6a1249589f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a6a1249589f, replyNumber=0, likeNumber=0, createdTime=2017-12-29, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a6a1249589f, moduleTitle=Hepatology：“普通”vs“优先”丙肝治疗方案哪个更具有成本效果？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a6a1249589f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905061, encodeId=cbc4190506197, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=J Gastroenterol Hepatol：采用无干扰素治疗方案治疗1天后，患者血清HCV-RNA水平降低的临床意义, objectType=article, longId=140487, objectId=f2af14048ea5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f2af14048ea5, replyNumber=0, likeNumber=57, createdTime=2018-07-09, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f2af14048ea5, moduleTitle=J Gastroenterol Hepatol：采用无干扰素治疗方案治疗1天后，患者血清HCV-RNA水平降低的临床意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f2af14048ea5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905053, encodeId=ebf5190505338, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Janssen收购BeneVir Biopharm以推进免疫治疗方案, objectType=article, longId=137195, objectId=7b7713e1954a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b7713e1954a, replyNumber=0, likeNumber=71, createdTime=2019-02-17, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b7713e1954a, moduleTitle=Janssen收购BeneVir Biopharm以推进免疫治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b7713e1954a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905052, encodeId=433d19050522c, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=JAMA：持续性哮喘患者哪种治疗方案能防止哮喘加重？, objectType=article, longId=137030, objectId=521313e0308b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=521313e0308b, replyNumber=0, likeNumber=89, createdTime=2018-07-07, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=521313e0308b, moduleTitle=JAMA：持续性哮喘患者哪种治疗方案能防止哮喘加重？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=521313e0308b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905012, encodeId=3a1619050121e, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Eur Urol：不同初始治疗方案对局限性前列腺癌患者的长期心理和生活质量影响。, objectType=article, longId=111165, objectId=160d1111650e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=160d1111650e, replyNumber=0, likeNumber=59, createdTime=2018-05-15, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=160d1111650e, moduleTitle=Eur Urol：不同初始治疗方案对局限性前列腺癌患者的长期心理和生活质量影响。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=160d1111650e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905044, encodeId=a941190504453, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Blood：brentuximab vedotin联合环磷酰胺、阿霉素和强的松作为一线治疗方案用于外周T细胞淋巴瘤患者的疗效和安全性, objectType=article, longId=131784, objectId=6781131e84a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6781131e84a3, replyNumber=0, likeNumber=69, createdTime=2019-01-06, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6781131e84a3, moduleTitle=Blood：brentuximab vedotin联合环磷酰胺、阿霉素和强的松作为一线治疗方案用于外周T细胞淋巴瘤患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6781131e84a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905040, encodeId=a770190504067, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Eur J Cancer：根据HR+HER2+乳腺癌患者年龄选择更佳内分泌辅助治疗方案, objectType=article, longId=129991, objectId=253512999129, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=253512999129, replyNumber=0, likeNumber=54, createdTime=2018-05-25, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=253512999129, moduleTitle=Eur J Cancer：根据HR+HER2+乳腺癌患者年龄选择更佳内分泌辅助治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=253512999129)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905055, encodeId=d9401905055c0, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=JACC：系统STEMI治疗方案可改善女性患者的预后, objectType=article, longId=137784, objectId=9c7013e7844a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c7013e7844a, replyNumber=0, likeNumber=58, createdTime=2018-08-08, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c7013e7844a, moduleTitle=JACC：系统STEMI治疗方案可改善女性患者的预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c7013e7844a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905031, encodeId=773c19050314d, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Am J Gastroenterol：炎症性肠病治疗方案的辅助决策, objectType=article, longId=122685, objectId=0cde122685a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0cde122685a2, replyNumber=0, likeNumber=68, createdTime=2018-10-19, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0cde122685a2, moduleTitle=Am J Gastroenterol：炎症性肠病治疗方案的辅助决策, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0cde122685a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905034, encodeId=0cef190503419, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=UROLOGY：非转移性高危肾细胞癌应用ASSURE (ECOG-ACRIN 2805)治疗方案, objectType=article, longId=124016, objectId=891512401660, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=891512401660, replyNumber=0, likeNumber=66, createdTime=2018-02-15, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=891512401660, moduleTitle=UROLOGY：非转移性高危肾细胞癌应用ASSURE (ECOG-ACRIN 2805)治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=891512401660)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905017, encodeId=a851190501e42, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=患者拒绝了我的治疗方案，该怎么沟通？, objectType=article, longId=113878, objectId=d4871138e800, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4871138e800, replyNumber=0, likeNumber=70, createdTime=2018-02-12, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4871138e800, moduleTitle=患者拒绝了我的治疗方案，该怎么沟通？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4871138e800)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905038, encodeId=6ec8190503851, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Diabetes：长链非编码RNA（LncSHGL）通过募集hnRNPA1来抑制肝糖异生和脂肪合成，为糖尿病和脂肪肝提供新的潜在治疗方案, objectType=article, longId=128489, objectId=e30312848978, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e30312848978, replyNumber=0, likeNumber=60, createdTime=2018-08-29, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e30312848978, moduleTitle=Diabetes：长链非编码RNA（LncSHGL）通过募集hnRNPA1来抑制肝糖异生和脂肪合成，为糖尿病和脂肪肝提供新的潜在治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e30312848978)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905021, encodeId=9639190502184, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=Ophthalmologica：视网膜中心静脉阻塞导致黄斑水肿的抗血管内皮生长因子治疗方案比较研究！, objectType=article, longId=115307, objectId=dabb11530e33, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dabb11530e33, replyNumber=0, likeNumber=0, createdTime=2018-06-06, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dabb11530e33, moduleTitle=Ophthalmologica：视网膜中心静脉阻塞导致黄斑水肿的抗血管内皮生长因子治疗方案比较研究！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dabb11530e33)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1905032, encodeId=07531905032b7, content=<a href='/topic/show?id=21f66464823' target=_blank style='color:#2F92EE;'>#治疗方案#</a>, objectTitle=【2017 ASH】复发难治性慢性淋巴细胞白血病17p缺失突变患者治疗方案的选择——伊布替尼vs HSCT, objectType=article, longId=123311, objectId=ff8a12331154, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff8a12331154, replyNumber=0, likeNumber=17, createdTime=2018-03-15, rootId=0, userName=zhangjiqing, userId=5ee4187, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff8a12331154, moduleTitle=【2017 ASH】复发难治性慢性淋巴细胞白血病17p缺失突变患者治疗方案的选择——伊布替尼vs HSCT, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff8a12331154)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

治疗方案

2020-05-29

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

JAMA：体外放疗+雄激素剥夺治疗+近距离治疗是Gleason评分9-10分前列腺癌患者更佳治疗方案

2018-12-08

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

曙光！老年不稳定性心绞痛或将迎来新的治疗方案

2018-08-26

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

J Endod：牙髓病医师的牙髓再生治疗方案：一项网络调查

2018-04-03

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Leuk Lymphoma：急性白血病老年患者应采用何种治疗方案？

2018-04-26

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

J Endod：CBCT对颈部外吸收治疗方案以及一项新型轴向片层分类系统的影响

2018-10-19

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

JACC：他汀相关肌肉疾病的患者如何优化胆固醇治疗方案？

2018-05-21

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Hepatology：“普通”vs“优先”丙肝治疗方案哪个更具有成本效果？

2017-12-29

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

J Gastroenterol Hepatol：采用无干扰素治疗方案治疗1天后，患者血清HCV-RNA水平降低的临床意义

2018-07-09

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Janssen收购BeneVir Biopharm以推进免疫治疗方案

2019-02-17

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

JAMA：持续性哮喘患者哪种治疗方案能防止哮喘加重？

2018-07-07

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Eur Urol：不同初始治疗方案对局限性前列腺癌患者的长期心理和生活质量影响。

2018-05-15

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Blood：brentuximab vedotin联合环磷酰胺、阿霉素和强的松作为一线治疗方案用于外周T细胞淋巴瘤患者的疗效和安全性

2019-01-06

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Eur J Cancer：根据HR+HER2+乳腺癌患者年龄选择更佳内分泌辅助治疗方案

2018-05-25

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

JACC：系统STEMI治疗方案可改善女性患者的预后

2018-08-08

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Am J Gastroenterol：炎症性肠病治疗方案的辅助决策

2018-10-19

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

UROLOGY：非转移性高危肾细胞癌应用ASSURE (ECOG-ACRIN 2805)治疗方案

2018-02-15

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

患者拒绝了我的治疗方案，该怎么沟通？

2018-02-12

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Diabetes：长链非编码RNA（LncSHGL）通过募集hnRNPA1来抑制肝糖异生和脂肪合成，为糖尿病和脂肪肝提供新的潜在治疗方案

2018-08-29

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

Ophthalmologica：视网膜中心静脉阻塞导致黄斑水肿的抗血管内皮生长因子治疗方案比较研究！

2018-06-06

zhangjiqing (审核中...)

前往app查看评论内容

#治疗方案#

【2017 ASH】复发难治性慢性淋巴细胞白血病17p缺失突变患者治疗方案的选择——伊布替尼vs HSCT

2018-03-15

科室
- - 订阅+
  - 更多科室
工具
服务